Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Co-Pay Subsidies From Pharma At Odds With Goals Of Health Reform - Medco

This article was originally published in The Pink Sheet Daily

Executive Summary

From a health care reform perspective, the industry's increasing practice of providing subsidies that help keep patients on higher cost drugs "is a really bad thing to do" and "should not be allowed," Chairman Snow comments during PBM's earnings call.
Advertisement

Related Content

Can Pharma Industry Afford To Give Up More For Health Reform? PhRMA Calls President "Misinformed"
PhRMA Health Reform Deal Is Not Binding On House, Rep. Waxman Declares
PhRMA Health Reform Deal Is Not Binding On House, Rep. Waxman Declares

Topics

Advertisement
UsernamePublicRestriction

Register

PS069762

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel